Christopher R Cogle

Christopher R Cogle, M.D.

Professor Of Medicine

Department: MD-HEMATOLOGY/ONCOLOGY
Business Phone: (352) 273-7493

About Christopher R Cogle

Christopher R. Cogle, M.D. is a physician, scientist, and professor of hematology and oncology at the University of Florida. Through mentored career awards from the National Institutes of Health (NIH K08) and the American Society of Clinical Oncology, he discovered that adult blood stem cells make blood vessels. He used that discovery to invent and patent new therapeutics for patients with blood cancers and cardiovascular diseases. He has been named a Top 10 Young Stem Cell Scientist by the British Council, a Scholar in Clinical Research by The Leukemia & Lymphoma Society, and his clinic has been designated a Center of Excellence by The Myelodysplastic Syndromes Foundation. He founded two startup companies, CancerPOP and addon, based on his inventions. Dr. Cogle teaches two literature courses to University of Florida undergraduates: one entitled “Physician Writers in the Postmodern Era” and the other on “Literature, Illness, and the Outwardly Healthy Reader.” Civic engagement is a priority for Dr. Cogle beginning in his early days in Scouting. He is currently a Den Leader in his children’s Cub Scout Pack. He has produced two documentaries – “The Gap” and “A Narrow Catch” – that shed light on systemic injustices in the American health system. Dr. Cogle led the State of Florida’s effort in crafting and implementing the Florida Cancer Plan, as elected Chairperson of the Florida Cancer Control and Research Advisory Council. Dr. Cogle is selected by the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar. In this program, Dr. Cogle is expanding his health policy efforts to national and international challenges in health promotion, disease prevention, and disease control.

Accomplishments

Emerging Leader in Health and Medicine Scholar
2020 · National Academy of Medicine
Clinical Trials Award
2018 · UF Health Cancer Center
Research Prize
2016 · Harvard Business School Precision Trials Challenge
Research Prize
2016 · UF Department of Medicine
Research Prize
2014 · UF Department of Medicine
Customer Service Key Award for Excellent Patient Care
2013 · UF Health Shands Hospital
Bench to Bedside Award
2012 · University of Florida
Research Award
2012 · UF Department of Medicine
Scholar in Clinical Research
2012 · Leukemia and Lymphoma Society
Best in Research
2011 · University of Florida
Center of Excellence in Myelodysplastic Syndromes
2009 · MDS Foundation
Excellence in Teaching Award
2008 · University of Florida
Best in Research
2006 · University of Florida
Top 10 US Young Stem Cell Scientist
2005 · British Council
First Prize in Research
2004 · Joint Cancer Conference of the Florida Universities
Young Investor Award
2003 · American Society of Clinical Oncology
NIH Loan Repayment Award
2002 · NIH
Alpha Omega Alpha
1998 · Alpha Omega Alpha
Vigil Honor
1989 · Order of the Arrow
Eagle Scout
1987 · Boy Scouts of America

Board Certifications

  • Oncology
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Oncology
Areas of Interest
  • Acute myeloid leukemia (AML) – children
  • Acute myeloid leukemia – adult
  • Aplastic anemia
  • Bone marrow aspiration
  • Bone marrow biopsy
  • Bone marrow culture
  • Bone marrow transplant
  • Cancer – resources
  • Cancer treatment information
  • Cord blood transplantation
  • Diet – cancer treatment
  • Diet and cancer
  • Genetics
  • Myelodysplastic Syndromes (MDS)
  • Myelodysplastic syndrome
  • Secondary aplastic anemia
  • Stem cell research

Research Profile

Christopher R. Cogle, M.D. is a physician and scientist with research focus on cancer and health policy. In his early career Dr. Cogle discovered that blood stem cells make blood vessels and used that biology to invent new therapeutics and diagnostics for people with cancer and heart disease. In his mid career, as a Leukemia & Lymphoma Society Scholar in Clinical Research, he began translating research discoveries into investigator-initiated clinical trials. Dr. Cogle has also made major discoveries in cancer epidemiology and was elected to lead Florida’s cancer prevention and control efforts at the state level, producing the Florida Cancer Plan, leading statewide campaigns for improved cancer prevention and control, and advising the Florida Legislature, Florida Secretary of Health, and Florida Governor on evidence-based strategies to reduce the state’s cancer burden. In 2020, Dr. Cogle was selected by the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar. As a Scholar he works to increase access to high quality health care by studying and improving health policies of government entities and health systems.

Open Researcher and Contributor ID (ORCID)

0000-0001-5422-6863

Areas of Interest
  • Allogeneic Hematopoietic Cell Transplantation
  • Bone marrow transplantation
  • Cancer
  • Cancer Genetics
  • Cancer Informatics
  • Cancer Screening
  • Cancer prevention
  • Digital Health
  • Genetics
  • Haplo-identical Stem Cell Transplantation
  • Health Outcomes
  • Health Policy
  • Health outcomes research
  • Healthcare policies
  • Leukemia
  • Population Health
  • Targeted Cancer Therapy
  • Telehealth
  • health services research

Publications

2019 International Journal of Environmental Research and Public Health
2012 Cancer Epidemiology Biomarkers & Prevention
2006 Paediatric respiratory reviews
2004 Experimental Hematology

Grants

Jun 2018 – Jun 2019
Pilot Study of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes
CELGENE CORP · Principal Investigator
Nov 2017 ACTIVE
The Harry T. Mangurian, Jr. Foundation – Support for the Study of Therapy Resistant Leukemia
UF FOU · Project Manager
Jun 2017 ACTIVE
DRPD-R0F2017: An Integrated Multi-'omics' Analysis of Myelodysplastic Syndromes
UF DSR OPPORTUNITY FUND ·
Jun 2017 – May 2018
Laboratory Studies of Acute Lymphoblastic Leukemia
CELL WORKS GROUP, INC. · Principal Investigator
Apr 2017 ACTIVE
OoR CTSI Institutional Matching Support
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
May 2016 – Dec 2017
Beat AML Project: Personalized Medicine for AML Based on Functional Genomics
OREGON HLTH SCIENCES UNIV · Principal Investigator
Jan 2016 ACTIVE
Miscellaneous Donors
MISCELLANEOUS DONORS · Principal Investigator
Oct 2015 – Dec 2017
Exploratory Analyses for OX1222
MATEON THERAPEUTICS · Principal Investigator
Sep 2015 – Oct 2019
Personalized Genomic Mutation Informed Treatment of Patients with Myelodysplastic Syndromes (MDS)
GATEWAY FOR CANCER RESEARCH · Principal Investigator
Feb 2015 – Jan 2020
UF Health Cancer Center Collaborative Cancer Related Seed Grant funded through the Florida Consortium of National Cancer Institute Centers Program
UF HEALTH SHANDS HOSPITAL · Project Manager
Nov 2014 – Oct 2015
Mapping Cancer in Alachua County
UF MEDICAL GUILD · Principal Investigator
Oct 2014 ACTIVE
Connect MDS/AML Disease Registry
UNITED BIOSOURCE · Principal Investigator
Jan 2014 – Jul 2018
Anemia and the Chronic Hyperadrenergic State following M
NATL INST OF HLTH NIGMS · Project Manager
Jan 2014 – Dec 2016
Role of the Microenvironment in Acute Myeloid Leukemia
LEUKEMIA & LYMPHOMA SOC · Principal Investigator
Dec 2013 – Nov 2016
Targeting Histone Methylation for Triple-Negative Breast
FL DEPT OF HLTH BANKHEAD-COLEY CANCER RE · Project Manager
Sep 2013 ACTIVE
Chagnon Professorship – research in field of stem cell biology and bone marrow transplantation
UF FOU · Project Manager
Jul 2012 – Jun 2017
Vascular Targeting Therapy in AML and MDS
LEUKEMIA & LYMPHOMA SOC · Principal Investigator
Mar 2012 – Mar 2016
A prospective, randomized, double-blinded, active-control and unblindedstandard of care (SOC) controlled study to determine the efficacy and safety oftargeted intramyocardial delivery of autologous CD34+ cells (Auto-CD34+cells) for increasing exerc
PPD DEVELOPMENT · Project Manager
Mar 2012 ACTIVE
UFRCC for Cardiovascular Cell Therapy Research Network
NATL INST OF HLTH NHLBI ·
Feb 2012 – May 2017
A Prospective Randomized Double Blinded Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients with Acute Myocardial Infarction
AMORCYTE · Project Manager
Feb 2012 ACTIVE
Davis Cancer Endowment – #F014842
UF FOU · Project Manager
Feb 2012 – Jan 2019
Novel technology for targeting and eliminating cancer ce
UF FOU · Principal Investigator
Nov 2009 – Dec 2016
COMFORT-1
PPD DEVELOPMENT · Principal Investigator
Jun 2008 – Nov 2019
Azacitidine
CELGENE CORP · Principal Investigator
Jul 2007 – Aug 2016
Clinical and Translational Science Institute
UF RESEARCH FOU · Project Manager
Jul 2006 ACTIVE
21st Century (REDIP)
STATE UNIV SYS OF FL BOARD OF GOVERNORS · Project Manager

Patents

Published July 2011
Modulating Angiogenesis (CIP) Parent 10699
#US-2011-0280874-A1
Issued August 2017
Use of Myxoma Virus to Prevent Graft-US-Host Disease
#9,730,960
Published April 2018
Polyamine Sulfonamides and Uses Thereof
#US-2018-0297942-A1

Education

Fellowship – Medical Oncology
2003 · University of Florida
Fellowship – Blood & Marrow Transplant and Stem Cell Biology
2003 · Duke University
Residency – Internal Medicine
2000 · University of Florida
Medical Doctorate (M.D.)
1997 · University of Florida
Bachelor of Science (B.S.) in Biomedical Sciences
1994 · University of Florida

Contact Details

Phones:
Business:
(352) 273-7493